بدائل البحث:
point decrease » point increase (توسيع البحث)
teer decrease » mean decrease (توسيع البحث), greater decrease (توسيع البحث)
nn decrease » _ decrease (توسيع البحث), mean decrease (توسيع البحث), gy decreased (توسيع البحث)
a decrease » _ decrease (توسيع البحث), _ decreased (توسيع البحث), _ decreases (توسيع البحث)
1 point » _ point (توسيع البحث), 5 point (توسيع البحث), _ points (توسيع البحث)
point decrease » point increase (توسيع البحث)
teer decrease » mean decrease (توسيع البحث), greater decrease (توسيع البحث)
nn decrease » _ decrease (توسيع البحث), mean decrease (توسيع البحث), gy decreased (توسيع البحث)
a decrease » _ decrease (توسيع البحث), _ decreased (توسيع البحث), _ decreases (توسيع البحث)
1 point » _ point (توسيع البحث), 5 point (توسيع البحث), _ points (توسيع البحث)
-
221
-
222
-
223
-
224
-
225
-
226
Tunicamycin produces a concentration- and time-dependent decrease in cell viability in SH-SY5Y cells concomitant with caspase-3 activation.
منشور في 2013"…<p>(A) Treatment of SH-SY5Y cells with tunicamycin (0.1–5µM) for 24 h caused a progressive decrease in cell viability as measured by Calcein AM cleavage assay. …"
-
227
-
228
-
229
-
230
Fenretinide decreases levels of PAX3/FOXO1 and its target genes in aRMS cell lines.
منشور في 2013"…D) Fenretinide did not decrease mRNA levels of FOXO1 in aRMS cells. qRT–PCR was carried out after treatment with an IC<sub>50</sub> concentration of fenretinide during different time points (24–48–72 hours). …"
-
231
-
232
T-maze performance is associated with dynamic, speed-independent regulation of hippocampal theta frequency at the choice point.
منشور في 2016"…Each point represents one session (segregated by delay length) for a given rat.…"
-
233
-
234
-
235
-
236
-
237
-
238
-
239
-
240
Lithium Decreases Glial Fibrillary Acidic Protein in a Mouse Model of Alexander Disease
منشور في 2015"…Lithium reduced the levels of phosphorylated STAT3, suggesting this as one pathway mediating the effects on GFAP. In conclusion, lithium has the potential to decrease GFAP levels in Alexander disease, but with a narrow therapeutic window separating efficacy and toxicity.…"